FRIENDSWOOD, Texas, July 14, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the second quarter ended June 30, 2025, after the close of market on Monday, Aug. 4, 2025. Company management will host a conference call and webcast to discuss its financial results at 4:30 p.m.

LEXINGTON, S.C. and SANDY SPRINGS, Ga.

64 Valvoline Instant Oil Change℠ locations in New England are participating in "A Chance for Kids & Families®" program for the 12th consecutive year to raise money for Dana-Farberand the Jimmy Fund BOSTON , July 14, 2025 /PRNewswire/ -- Valvoline Instant Oil Change (VIOC) locations throughout New England are helping Dana-Farber Cancer Institute and the Jimmy Fund to defy cancer this summer through their participation in the "A Chance for Kids & Families®" program. Customers are invited to donate $1, $5, or $10 at a participating Valvoline Instant Oil Change location between July 13 and August 2 to do their …

CAMBRIDGE, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced the company will host a conference call and live webcast on Thursday, July 31, 2025, at 8:00 a.m.

MINNEAPOLIS , July 14, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western™ Technology played a key role in supporting the FDA approval of ZEVASKYN™ (prademagene zamikeracel), the first autologous cell-based gene therapy for patients with recessive dystrophic epidermolysis bullosa (RDEB), developed by Abeona Therapeutics® (NASDAQ: ABEO). Throughout clinical development, Simple Western enabled precise identification and quantification of Collagen VII, a complex therapeutic target critical to ZEVASKYN's potency, supporting lot release testing for the viral vector and the cell therapy in a GMP setting.

NORTHBROOK, Ill. , July 14, 2025 /PRNewswire/ -- Stepan Company (NYSE: SCL) announced today the appointment of Ruben Velasquez as Vice President and Chief Financial Officer of Stepan, effective as of July 15, 2025.

HAUPPAUGE, N.Y., July 14, 2025 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”), announced today that Jason Brenner and Zack Schwartz were named Co-Heads of a newly established Lender Finance vertical.

Adding a fourth certified facility within its global network increases operational capacity to better serve international medical markets NASDAQ | TSX: ACB EDMONTON, AB , July 14, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce that its dedicated distribution centre located in Brampton, Ontario, has received European Union Good Manufacturing Practice ("EU-GMP") certification, increasing the company's international export capabilities. The distribution centre joins Aurora's group of manufacturing facilities in Canada and Europe certified against EU standards, demonstrating the company's unwavering commitment to regulatory excellence, end-to-end operational quality …

Gastrointestinal biomarker tests enhance patient diagnosis of IBD and pancreatic insufficiency on leading clinical chemistry platforms SAN DIEGO , July 14, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho") and BÜHLMANN Laboratories AG today announced the availability of the BÜHLMANN fCAL turbo and fPELA turbo assays on QuidelOrtho's VITROS Systems as an MPA. Both particle-enhanced turbidimetric immunoassays, the fCAL turbo assay for fecal calprotectin measurement aids in the diagnosis of inflammatory bowel disease (IBD) and its differentiation from irritable bowel syndrome, and the fPELA turbo assay for fecal pancreatic elastase aids in the determination of pancreatic insufficiency.

New U.S.-based role to support growth strategy, partnerships, and scaling of rhCollagen product platforms REHOVOT, Israel , July 14, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing disruptive technologies and products based on its non-animal-derived recombinant human collagen (rhCollagen), today announced the appointment of Bowman Bagley as Vice President, Commercial North America. In this newly created role, Mr.

LAS VEGAS, July 14, 2025 (GLOBE NEWSWIRE) -- Hyperscale Data, Inc. (NYSE American: GPUS), a diversified holding company (“Hyperscale Data” or the “Company”), today announced it has reduced its outstanding debt by more than $20 million, representing a significant milestone in its transformation into a pure-play artificial intelligence (“AI”) data center platform.

Tylenol maker Kenvue said on Monday Thibaut Mongon had stepped down as chief executive officer and board member.

BOCA RATON, Fla.--(BUSINESS WIRE)--The GEO Group, Inc. (NYSE: GEO) (“GEO” or the “Company”) announced today the closing of an amendment to the Company's Credit Agreement dated as of April 18, 2024 (the “Amendment”). The Amendment increases GEO's Revolving Credit Facility (the “Revolver”) commitments from $310 million to $450 million and extends the Revolver's maturity to July 14, 2030. The Amendment further provides that interest will accrue on outstanding revolving credit loans at a rate deter.

HOUSTON , July 14, 2025 /PRNewswire/ -- Quanta Services, Inc. (NYSE: PWR) announced today that it will release its second quarter 2025 financial results on Thursday, July 31, 2025, before the market opens. In conjunction with the press release, Quanta has scheduled a webcast and conference call for 9:00 a.m.

Nvidia stock started the week on a high note as CEO Jensen Huang appeared to reaffirm his company's commitment to the Chinese market.

Methanex's recent acquisitions in Texas and the Netherlands are expected to drive revenue and free cash flow growth, enhancing future financial performance. A major activist investor's stake could accelerate stock demand and potentially lead to value-creating actions like asset sales or share repurchases. Despite operational and debt-related risks, Methanex trades at a significant discount to peers and appears undervalued based on my DCF models.

EWCZ, DELL and ADRNY made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 14, 2025.

WINONA, Minn.--(BUSINESS WIRE)--Fastenal Company (Nasdaq:FAST) ('Fastenal', 'we', 'our', or 'us'), a leader in the wholesale distribution of industrial and construction supplies, today announced its financial results for the quarter ended June 30, 2025. Except for share and per share information, or as otherwise noted below, dollar amounts are stated in millions. All historical common stock share and per share information and stockholders' equity balances for all periods presented in this relea.

SHANGHAI, China, July 14, 2025 (GLOBE NEWSWIRE) -- Hesai Group (“Hesai” or the “Company”) (NASDAQ: HSAI), the global leader in three-dimensional light detection and ranging (lidar) solutions, today announces that it has filed a Notice of Appeal to the U.S. Court of Appeals on July 13, 2025, to challenge the decision of the U.S. District Court for the District of Columbia (“District Court”), which upheld the U.S. Department of Defense's (DoD) designation of the Company under Section 1260H of the National Defense Authorization Act for Fiscal Year 2021.

A report released by India's Aircraft Accident Investigation Bureau pointed to fuel switches that flipped off during takeoff, depriving engines of power.